Erratum: Expression of Concern: Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines (PLoS ONE (2017) 12:3 (e0173965) DOI: 10.1371/journal.pone.0173965);Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Kim, Shin Hee ^a   Chen, Zongyan ^a   Yoshida, Asuka ^a   Paldurai, Anandan ^a   Xiao, Sa ^a   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOTYPE MATCHED VACCINE; HYBRID PROTEIN; LIVE VACCINE; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS ANTIBODY; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ANTIBODY TITER; ARTICLE; AVULAVIRUS; AVULAVIRUS SEROTYPE 2; AVULAVIRUS SEROTYPE 3; AVULAVIRUS SEROTYPE 4; AVULAVIRUS SEROTYPE 6; AVULAVIRUS SEROTYPE 7; AVULAVIRUS SEROTYPE 8; AVULAVIRUS SEROTYPE 9; CELL TO CELL FUSION; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CLEAVAGE SITE SEQUENCE; CONTROLLED STUDY; DRUG EFFICACY; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MUTATIONAL ANALYSIS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; NEWCASTLE DISEASE VIRUS STRAIN LASOTA; NEWCASTLE DISEASE VIRUS STRAIN MEXICO/01/10; NONHUMAN; PROTEIN ANALYSIS; REVERSE GENETICS; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE; ANIMAL; CHICKEN; GENETICS; IMMUNOLOGY; METABOLISM; VACCINATION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; VACCINATION; VIRAL FUSION PROTEINS; VIRAL VACCINES;

EID: 85016151754     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0244011     Document Type: Erratum

References (24)

1. Alexander DJ (1998) Newcastle disease and other avian paramyxoviruses. A laboratory manual for the isolation and identification of avian pathogens. American Association of Avian Pathologists, Kennett Square. pp 156-163.
2. Samal SK (2011) Newcastle disease and related avian paramyxoviruses, p. 69-114In: Samal S. K., editor. The biology of paramyxoviruses. Caister Academic Press.
3. Peeters BPH, de Leeuw OS, Koch G, Gielkens ALJ (1999) Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol. 73: 5001-5009. PMID: 10233962
4. Panda A, Huang Z, Elankumaran S, Rockemann DD, Samal SK (2004). Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb. Pathog. 36: 1-10. PMID: 14643634
5. Miller PJ, Decanini EL, Afonso CL (2010) Newcastle disease: Evolution of genotypes and the related diagnostic challenges. Infect. Genet. Evol. 10: 26-35. https://doi.org/10.1016/j.meegid.2009.09.012PMID: 19800028
6. Czeglédi A, Ujvári D, Somogyi E, Wehmann E, Werner O, Lomniczi B (2006) Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. Virus Res. 120: 36-48. https://doi.org/10.1016/j.virusres.2005.11.009 PMID: 16766077
7. Diel DG, da Silva LHA, Liu H, Wang Z, Miller PJ, Afonso CL (2012) Genetic diversity of avian paramyxovirus type 1: Proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect. Genet. Evol. 12: 1770-1779. https://doi.org/10.1016/j.meegid.2012.07.012 PMID: 22892200
8. Liu XF, Wan HQ, Ni XX, Wu YT, Liu WB (2003) Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985-2001. Arch. Virol. 148: 1387-1403. https://doi.org/10.1007/s00705-003-0014-z PMID: 12827467
9. Kapczynski DR, King DJ (2005) Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Vaccine 23: 3424-3433. https://doi.org/10.1016/j.vaccine.2005.01.140 PMID: 15837366
10. Miller PJ, King DJ, Afonso CL, Suarez DL (2007) Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25: 7238-7246. https://doi.org/10.1016/j.vaccine.2007.07.017 PMID: 17719150
11. Jeon WJ, Lee EK, Lee YJ, Jeong OM, Kim YJ, Kwon JH, et al. (2008) Protective efficacy of commercial inactivated Newcastle disease virus vaccines in chickens against a recent Korean epizootic strain. J. Vet. Sci. 9: 295-300. https://doi.org/10.4142/jvs.2008.9.3.295 PMID: 18716450
12. Hu Z, Hu S, Meng C, Wang X, Zhu J, Liu X (2011) Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs. Avian dis. 55: 391-397. https:// doi.org/10.1637/9633-122410-Reg.1 PMID: 22017036
13. Hu S, Ma H, Wu Y, Liu W, Wang X., Liu Y, et al. (2009) A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics. Vaccine 27: 904-910. https://doi.org/10.1016/ j.vaccine.2008.11.091 PMID: 19095026
14. Xiao S, Nayak B, Samuel A, Paldurai A, Kanabagattebasavarajappa M, Collins PL, et al. (2012) Generation by reverse genetics of an effective, stable, live-attenuated Newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLoS ONE 7: e52751. https://doi.org/10. 1371/journal.pone.0052751 PMID: 23285174
15. Xiao S, Paldurai A, Nayak B, Mirande A, Collins PL, Samal SK (2013) Complete genome sequence of a highly virulent Newcastle disease virus currently circulating in Mexico. Genome Announc. 1: e00177.
16. Miller PJ, Estevez C, Yu Q, Suarez DL, King DK (2009) Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis. 53: 39-49. https://doi.org/10.1637/8407-071208-Reg.1 PMID: 19432002
17. Huang Z, Krisnamurthy S, Panda A, Samal SK (2001) High-level expression of a foreign gene from the 3? proximal first locus of a recombinant Newcastle disease virus. J. Gen. Virol. 82: 1729-1736. https:// doi.org/10.1099/0022-1317-82-7-1729 PMID: 11413385
18. Cho SH, Kwon HJ, Kim TE, Kim JH, Yoo HS, Park MH, et al. (2008) Characterization of a recombinant Newcastle disease vaccine strain. Clin. Vaccine Immunol. 15: 1572-1579. https://doi.org/10.1128/CVI. 00156-08 PMID: 18768673
19. Dortmans JC, Peeters BP, Koch G (2012) Newcastle disease virus outbreaks: vaccine mismatch or inadequate application? Vet. Microbiol. 160: 17-22. https://doi.org/10.1016/j.vetmic.2012.05.003PMID: 22655976
20. Qin ZM, Tan LT, Xu HY, Ma BC, Wang YL, Yuan XY, et al. (2008) Pathotypical characterization and molecular epidemiology of Newcastle disease virus isolates from different hosts in China from 1996 to2005. J. Clin. Microbiol. 46: 601-611. https://doi.org/10.1128/JCM.01356-07 PMID: 18077643
21. Perozo F, Merino R, Afonso CL, Villegas P, Calderon N (2008) Biological and phylogenetic characterization of virulent Newcastle disease virus circulating in Mexico. Avian Dis. 52: 472-479. https://doi.org/ 10.1637/8276-022908-Reg.1 PMID: 18939638
22. Susta L, Hamal KR, Miller PJ, Cardenas-Garcia S, Brown CC, Pedersen JC, et al. (2014) Separate evolution of virulent Newcastle disease viruses from Mexico and Central America. J. Clin. Microbiol. 52: 1382-1390. https://doi.org/10.1128/JCM.00066-14 PMID: 24523463
23. de Leeuw OS, Hartog L, Koch G, Peeters BP (2003) Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brain. J. Gen. Virol. 84: 475-484. https://doi.org/10.1099/vir.0.18714-0 PMID: 12560582
24. Kim SH, Wanasen N, Paldurai A, Xiao S, Collins PL, Samal SK (2013) Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine. PLoS ONE 8: e74022. https://doi.org/10.1371/journal.pone.0074022 PMID: 24015313